...
机译:NRF2活化剂TBHQ和CDDO-IM对T细胞激活早期事件的差异影响
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Michigan State Univ Dept Pharmacol &
Toxicol Life Sci Bldg 1355 Bogue St E Lansing MI 48824 USA;
Nrf2; IL-2; IFN gamma; T cell; CDDO-Im; tBHQ; NF kappa B;
机译:NRF2活化剂TBHQ和CDDO-IM对T细胞激活早期事件的差异影响
机译:Nrf2激活物tBHQ抑制原代人CD4 T细胞的T细胞活化
机译:NRF2活化剂TBHQ抑制原发性鼠天然杀伤细胞的激活
机译:以4-ABP诱导的膀胱癌激活NRF2作为化学预防策略
机译:Nrf2在激活小鼠和人类主要CD4 T细胞中的作用
机译:Nrf2激活剂tBHQ和CDDO-Im对T细胞激活的早期事件的差异作用
机译:NRF2活化剂TBHQ和CDDO-IM对T细胞激活早期事件的差异影响